New blood pressure drug enters first human testing
NCT ID NCT06205628
Summary
This is an early safety study testing a new drug called ADX-850 in 28 people with mild to moderate high blood pressure. The main goal is to see how safe the drug is and how the body processes it. Researchers will also check if it affects blood pressure levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CMAX Clinical Research
Adelaide, South Australia, 5000, Australia
-
Clinitrials Pty Ltd
Perth, Australia
-
Linear Clinical Research
Nedlands, Western Australia, 6009, Australia
Conditions
Explore the condition pages connected to this study.